Atlas Trials

Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders

Clinical trial NCT00437086 · COMPLETED

Trial details

NCT number
NCT00437086
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Chronic Myeloproliferative DisordersLeukemia
Start date
2005-09-01
Primary completion
2008-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.